Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: A prospective randomized controlled study

British Journal of Dermatology

Volumn 167, Issue 1, 2012, Pages 110-115

  Van Der Geer, Simone ^a   Martens, J ^a   Van Roij, J ^a   Brand, E ^a   Ostertag, J U ^a   Verhaegh, M E J M ^a   Neumann, H A M ^b   Krekels, G A M ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BLEEDING; CONTROLLED STUDY; CREAM; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; EROSION; ERYTHEMA; FACE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; MOHS MICROGRAPHIC SURGERY; NODULAR BASAL CELL CARCINOMA; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN CRUST; SKIN DISEASE; SKIN EDEMA; SKIN IRRITATION; SKIN PAIN; SKIN SCALING; SURGICAL DEFECT SIZE; TUMOR VOLUME;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; AGED; AMINOQUINOLINES; CARCINOMA, BASAL CELL; FACIAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; OINTMENTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84863311081     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10924.x     Document Type: Article

References (22)

1. Margoob A. Basal and squamous cell carcinomas. What every primary care physician should know. Postgrad Med 1997; 102:139-54.
2. Smeets N, Kuijpers D, Nelemans P et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face. Results of a retrospective study and review of the literature. Dermatol Surg 2004; 151:141-7. (Pubitemid 39061291)
3. Smeets N, Krekels G, Ostertag J et al. Surgical excision vs Mohs' micrographic surgery for basal cell carcinoma of the face: randomised controlled trial. Lancet 2004; 364:1766-72. (Pubitemid 39488061)
4. Beutner K, Geisse J, Helman D et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41:1002-7.
5. Marks R, Gebauer K, Schumack S et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001; 44:807-13. (Pubitemid 32391169)
6. Geisse J, Caro I, Lindholm J et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase 3, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50:722-33. (Pubitemid 38580549)
7. Geisse J, Rich P, Pandya A et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double blind, randomized, vehicle-controlled study. J Am Acad Dermatol 2002; 47:390-8.
8. Schumack S, Robinson J, Kossard S et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma. Arch Dermatol 2002; 138:1165-71. (Pubitemid 35025688)
9. Schulze H, Cribier B, Requena L et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase 3 study in Europe. Br J Dermatol 2005; 152:939-47. (Pubitemid 40704934)
10. Butler D, Parekh P, Lenis A. Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery. Dermatol Surg 2009; 35:24-9.
11. Thissen M, Kuijpers D, Krekels G. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases. J Drugs Dermatol 2006; 5:461-4.
12. Torres A, Niemeyer A, Berkes B et al. 5% Imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma. Dermatol Surg 2004; 30: 1462-9. (Pubitemid 40053555)
13. Peris K, Campione E, Micantonio T et al. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12 week open-label trial. Dermatol Surg 2005; 31:318-23. (Pubitemid 43072987)
14. Huber A, Huber J, Skinner R et al. Topical imiquimod treatment for nodular basal cell carcinomas: an open label series. Dermatol Surg 2004; 30:429-30. (Pubitemid 38524166)
15. Sterry W, Ruzicka T, Herrera E et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 2002; 147:1227-36. (Pubitemid 36963032)
16. Sexton M, Jones D, Maloney M. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990; 23:1118-26.
17. Reigenberger J, Ruzicka T. Basal cell carcinoma. In: Braun-Falco's Dermatology (Burgdorf WHC, Plewig G, Wolff HH, Landthaler M, eds), 3rd edn. Heidelberg: Springer-Verlag, 2009; 1348-56.
18. Moehrle M, Breuninger H, Schippert W, Häfner HM. Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study. Dermatol Surg 2010; 36:428-30.
19. Eigentler T, Kamin A, Weide B et al. A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol 2007; 57:616-21. (Pubitemid 47384927)
20. Sukal S, Mahlberg M, Brightman L et al. What lies beneath? A lesson for the clinician. Intraoperative frozen section appearance of persistent basal cell carcinoma after apparent cure with imiquimod 5% cream. Dermatol Surg 2009; 35:1831-4.
21. Wanitphakdeedecha R, Nguyen TH, Chen TM. Unit costs of Mohs and dermasurgery unit. J Eur Acad Dermatol Venereol 2010; 24:445-8.
22. Sapijaszko M. Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma. Skin Therapy Lett 2005; 10:2-5.